Last reviewed · How we verify
Mineral Tri-Oxide Aggregate — Competitive Intelligence Brief
marketed
Dentistry/Endodontics
Small molecule
Live · refreshed every 30 min
Target snapshot
Mineral Tri-Oxide Aggregate (Mineral Tri-Oxide Aggregate) — DR SURINDER SACHDEVA. Mineral Tri-Oxide Aggregate (MTA) is a biocompatible cement that sets through a hydration reaction, creating a hard matrix that seals and promotes healing in dental and endodontic applications.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mineral Tri-Oxide Aggregate TARGET | Mineral Tri-Oxide Aggregate | DR SURINDER SACHDEVA | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mineral Tri-Oxide Aggregate CI watch — RSS
- Mineral Tri-Oxide Aggregate CI watch — Atom
- Mineral Tri-Oxide Aggregate CI watch — JSON
- Mineral Tri-Oxide Aggregate alone — RSS
Cite this brief
Drug Landscape (2026). Mineral Tri-Oxide Aggregate — Competitive Intelligence Brief. https://druglandscape.com/ci/mineral-tri-oxide-aggregate. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab